A very exciting news regarding Breast cancer vaccine, and a Cov-19 vaccine that last a lifetime. ExpreS2ion announces submission of the COUGH-1 clinical trial application by the Prevent-nCoV consortium and Bavarian Nordic to review ABNCoV2 ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion”) announces that the clinical trial application (CTA) for a clinical Phase…